151 related articles for article (PubMed ID: 32641097)
1. The implementation and utility of patient screening logs in a multicentre randomised controlled oncology trial.
Lewis R; Todd R; Newton M; Jones RJ; Wilson C; Donovan JL; Bryan RT; Birtle A; Hall E;
Trials; 2020 Jul; 21(1):629. PubMed ID: 32641097
[TBL] [Abstract][Full Text] [Related]
2. Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.
Wilson C; Rooshenas L; Paramasivan S; Elliott D; Jepson M; Strong S; Birtle A; Beard DJ; Halliday A; Hamdy FC; Lewis R; Metcalfe C; Rogers CA; Stein RC; Blazeby JM; Donovan JL
Trials; 2018 Jan; 19(1):50. PubMed ID: 29351790
[TBL] [Abstract][Full Text] [Related]
3. Reasons for non-recruitment of eligible patients to a randomised controlled trial of secondary prevention after intracerebral haemorrhage: observational study.
Maxwell AE; MacLeod MJ; Joyson A; Johnson S; Ramadan H; Bellfield R; Byrne A; McGhee C; Rudd A; Price F; Vasileiadis E; Holden M; Hewitt J; Carpenter M; Needle A; Valentine S; Patel F; Harrington F; Mudd P; Emsley H; Gregary B; Kane I; Muir K; Tiwari D; Owusu-Agyei P; Temple N; Sekaran L; Ragab S; England T; Hedstrom A; Jones P; Jones S; Doherty M; McCarron MO; Cohen DL; Tysoe S; Al-Shahi Salman R
Trials; 2017 Apr; 18(1):162. PubMed ID: 28381307
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Do screening trial recruitment logs accurately reflect the eligibility criteria of a given clinical trial? Early lessons from the RAVES 0803 trial.
Sundaresan P; Turner S; Kneebone A; Pearse M; Fraser-Browne C; Woo HH
Clin Oncol (R Coll Radiol); 2014 Jun; 26(6):348-52. PubMed ID: 24685345
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study).
Shepherd V; Thomas-Jones E; Ridd MJ; Hood K; Addison K; Francis NA
Trials; 2017 Nov; 18(1):533. PubMed ID: 29126461
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
[TBL] [Abstract][Full Text] [Related]
10. Understanding variations in patient screening and recruitment in a multicentre pilot randomised controlled trial: a vignette-based study.
Hilton P; Buckley BS; McColl E; Howel D; Tincello DG; Brennand C;
Trials; 2016 Oct; 17(1):522. PubMed ID: 27782847
[TBL] [Abstract][Full Text] [Related]
11. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
13. The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial.
Parker A; Knapp P; Treweek S; Madhurasinghe V; Littleford R; Gallant S; Sullivan F; Schembri S; Rick J; Graffy J; Collier DJ; Eldridge S; Kennedy A; Bower P
Trials; 2018 Sep; 19(1):503. PubMed ID: 30227890
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
[TBL] [Abstract][Full Text] [Related]
16. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
17. Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study.
Menon U; Gentry-Maharaj A; Ryan A; Sharma A; Burnell M; Hallett R; Lewis S; Lopez A; Godfrey K; Oram D; Herod J; Williamson K; Seif M; Scott I; Mould T; Woolas R; Murdoch J; Dobbs S; Amso N; Leeson S; Cruickshank D; McGuire A; Campbell S; Fallowfield L; Skates S; Parmar M; Jacobs I
BMJ; 2008 Nov; 337():a2079. PubMed ID: 19008269
[TBL] [Abstract][Full Text] [Related]
18. Study recruitment factors in advanced cancer: the Prognosis in Palliative care Study II (PiPS2) - a multicentre, prospective, observational cohort project.
Kalpakidou AK; Todd C; Omar RZ; Keeley V; Griffiths J; Spencer K; Vickerstaff V; Christidoulides K; Perry R; Katsampa D; Stone P
BMJ Support Palliat Care; 2021 May; ():. PubMed ID: 33952580
[TBL] [Abstract][Full Text] [Related]
19. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
[TBL] [Abstract][Full Text] [Related]
20. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
